With a strong focus on characterizing molecular interactions exactly as they occur in the human body, our team provides customers with biologically relevant information to improve efficiency and performance of pharmaceutical drug development.
Attana’s third generation biosensors are today used to determine specificity, kinetics and affinity -among other binding characteristics- of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Our technology has been validated by academic institutions, biotech companies and big-pharma across the world.
We are headquartered in Stockholm and have a strong presence in Europe and Asia.
Get in touch for a more detailed discussion, contact us.
After 15 years of continuous development and improvements, our third generation biosensor understands the complex world of cell interactions.
Attana’s system can not only unravel biochemical pathways between (bio)molecules but can also shed light on (bio)molecules – cell interactions, determine off-target interactions and perform assays with crude samples and in sera, providing in that way a wealth of biologically relevant information.
Some of our team members
Dr Teodor Aastrup
CEO & Co-founder of Attana
Long experience of RnD and product and commercial strategies. Ph.D. at KTH and master of science in Material Physics from Uppsala University. Previous responsible for chemical analysis at Scania. Based on the technology he developed as Ph.D. student combined with industrial experiences from Scania Teodor co-founded Attana and has managed the companie's technical and commercial developed since then.
M.Sc. Samuel Altun
M.Sc. from Stockholm University. 7 years at Attana; first as Application Specialist, then as Support Manager and currently the COO since October 2017.
Dr Diluka Peiris
Diluka graduated from University of Colombo, Sri Lanka in 2003 and subsequently obtained her PhD in Biochemistry from University of Westminster, U.K. in 2009. She pursued her post-doctoral training in cancer glycobiology in the same department at University of Westminster. In 2014, she joined Attana AB as an Application scientist.
Dr Maria Gianneli
Maria holds a PhD in Materials Science and Technology from the University of Crete, Greece. Her previous postdoctoral research focused on the detection of whole bacteria using acoustic wave sensors. Since July 2015, she is employed by Attana AB where she performs assays to analyze biomolecules / nanoparticles - biomolecules / cells interactions.